In an Ophthalmology Times article, Digital Diagnostics’ Founder and Executive Chairman, Michael D. Abramoff, MD, PhD, discusses the pivotal role of AI in advancing the early detection of diabetic retinopathy. Dr. Abramoff’s insights emphasize the significant impact that AI can have on health equity, underscoring the need for continuous innovation and adaptation in the field.
AI can aid with early detection of diabetic retinopathy